Last reviewed · How we verify
NCT03213600: NSOCOG
Neurostimulation-enhanced Behavioral Remediation of Social Cognition in Schizophrenia
NA trial testing transcranial Direct Current Stimulation tDCS in Behaviors and Mental Disorders. Withdrawn.
1 September 2019
Quick facts
| Lead sponsor | Hôpital le Vinatier |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | basic science |
| Start date | 1 November 2018 |
| Primary completion | 1 September 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- transcranial Direct Current Stimulation tDCS
Conditions studied
- Behaviors and Mental Disorders — all drugs for Behaviors and Mental Disorders →
Sponsor
Hôpital le Vinatier — full company profile →
Who can join
Adults 18 to 45, any sex, with Behaviors and Mental Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Social cognition concerns the understanding of how people think about others and how that, in turn, influences our behavior, feelings, and social interactions. schizophrenia social-cognitive impairment is profound (effect size D\>1.2), medication resistant and critically limits functional well-being . Social cognition involves complex patterns of coordinated activity within numerous cortical and subcortical networks, making it a difficult target for clinical neuroscience investigation. Yet, prior research demonstrates that sensory-perceptual dysfunction in schizophrenia can upwardly generalize into higher-order social-cognitive impairment making perception a tractable and fruitful approach for studying social cognition in schizophrenia. Here, the investigators explore how distortions in perception of temporal coincidence can contribute to the aberrant inferences of physical causation and social agency.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03213600
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hôpital le Vinatier trials
Trials by the same sponsor.
- NCT07428200 — Characterization of the Neural Bases of Mental Imagery in Individuals With Borderline Personality Disorder: An EEG Study · NA · not yet recruiting
- NCT07384819 — Duration of Moment in Autism · NA · not yet recruiting
- NCT06284382 — Interaction Between Early Trauma and Odor-induced Dopamine Release · NA · not yet recruiting
- NCT07119671 — Peer-aid and Hope Box · NA · not yet recruiting
- NCT06869915 — Homelessness and Prevalence of Neurodevelopmental Disorders · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03213600 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital le Vinatier
- Last refreshed: 22 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03213600.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing